7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Uremia D014511 33 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Mandibular Diseases D008336 5 associated lipids
Bone Resorption D001862 7 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Bone Neoplasms D001859 5 associated lipids
Fractures, Bone D050723 4 associated lipids
Osteoarthritis D010003 4 associated lipids
Carcinoma D002277 18 associated lipids
Osteonecrosis D010020 5 associated lipids
Heart Failure D006333 36 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Osteitis D010000 10 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Osteosarcoma D012516 50 associated lipids
Hip Fractures D006620 2 associated lipids
Osteolysis D010014 8 associated lipids
Hypothyroidism D007037 32 associated lipids
Osteoarthritis, Hip D015207 4 associated lipids
Vision Disorders D014786 10 associated lipids
Multiple Myeloma D009101 13 associated lipids
Osteoporosis D010024 12 associated lipids
Kidney Diseases D007674 29 associated lipids
Weight Gain D015430 101 associated lipids
Otosclerosis D010040 2 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Calcinosis D002114 5 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Bone Diseases, Metabolic D001851 9 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Obesity D009765 29 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Myocardial Infarction D009203 21 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Malocclusion D008310 3 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Periodontal Diseases D010510 15 associated lipids
Osteitis Deformans D010001 3 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Crohn Disease D003424 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Fractures, Stress D015775 2 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Thyroid Diseases D013959 8 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Paraneoplastic Syndromes D010257 4 associated lipids
Sepsis D018805 11 associated lipids
Periodontal Pocket D010514 9 associated lipids
Brain Infarction D020520 17 associated lipids
Hirsutism D006628 3 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Hypocalcemia D006996 12 associated lipids
Brain Ischemia D002545 89 associated lipids
Endocrine System Diseases D004700 4 associated lipids
Nerve Degeneration D009410 53 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Periodontitis D010518 22 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Polycythemia Vera D011087 13 associated lipids
Mucocutaneous Lymph Node Syndrome D009080 9 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Cardiomyopathies D009202 10 associated lipids
Disease Susceptibility D004198 12 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Tsuruda T et al. Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. 2016 Hypertension pmid:27001297
Kats A et al. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. 2016 J. Cell. Mol. Med. pmid:26987561
Moran CS et al. Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. 2016 Arterioscler. Thromb. Vasc. Biol. pmid:26966276
Cong Q et al. p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. 2016 Stem Cell Reports pmid:26947973
Wang C et al. Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. 2016 Med. Sci. Monit. pmid:26939934
Lin J et al. Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. 2016 Nat Commun pmid:26923114
D'Abramo A et al. Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. 2016 PLoS ONE pmid:26913505
Lu J et al. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. 2016 Exp. Biol. Med. (Maywood) pmid:26908571
Theodoro LH et al. Effect of low-level laser therapy as an adjuvant in the treatment of periodontitis induced in rats subjected to 5-fluorouracil chemotherapy. 2016 J. Periodont. Res. pmid:26750739
Alam I et al. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. 2016 Endocrinology pmid:26584014
Mitchell JA et al. Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. 2016 J. Bone Miner. Res. pmid:26572781
Liu YD et al. Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. 2016 Osteoarthr. Cartil. pmid:26256766
Liu G et al. Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. 2016 Cell Tissue Res. pmid:26004143
Bergamini A et al. Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. 2016 Int J Med Sci pmid:28090190
Toffoli B et al. Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. 2016 Mediators Inflamm. pmid:28070143
Chen H et al. [Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. 2016 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:28070039
Røysland R et al. Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. 2016 PLoS ONE pmid:27463973
Piemontese M et al. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:27460899
Zhao JJ et al. MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. 2016 PLoS ONE pmid:27459539
Ugay L et al. Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. 2016 Chin. Med. J. pmid:27411457
Pellegrini GG et al. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. 2016 Nutrients pmid:27409635
Nagy EE et al. High circulating osteoprotegerin levels are associated with non-zero blood groups. 2016 BMC Cardiovasc Disord pmid:27387019
Zhang YY et al. Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. 2016 Chin J Dent Res pmid:27379348
Sasso GR et al. Elevated serum osteoprotegerin levels in women: friend or foe? 2015 Nov-Dec Rev Assoc Med Bras (1992) pmid:26841162
Calasans-Maia MD et al. Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. 2015 Nov-Dec J Appl Oral Sci pmid:26814461
Jianru YI et al. Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. 2015 Nov-Dec J Appl Oral Sci pmid:26814456
SaÄŸlam M et al. Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. 2015 Jan-Feb J Appl Oral Sci pmid:25760266
Esteghamati A et al. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. 2015 Aug-Sep Arch Cardiovasc Dis pmid:26184866
Li G et al. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. 2015 Int J Clin Exp Pathol pmid:26884838
Schiro A et al. Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. 2015 Sci Rep pmid:26564003
Mizuno M et al. Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease. 2015 Sci Rep pmid:26561427
Morisawa T et al. Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease. 2015 Int Heart J pmid:26549398
Beuselinck B et al. RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs. 2015 Br. J. Cancer pmid:26528707
Rewiuk K and Grodzicki T Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. 2015 Biomed Res Int pmid:26504794
Kao SY and Stankovic KM Transactivation of human osteoprotegerin promoter by GATA-3. 2015 Sci Rep pmid:26216189
Kassem A et al. TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss. 2015 FASEB J. pmid:26207027
Yang H et al. A novel model of bisphosphonate-related osteonecrosis of the jaw in rats. 2015 Int J Clin Exp Pathol pmid:26191212
Pitari MR et al. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. 2015 Oncotarget pmid:26160841
Hsu BG et al. High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. 2015 Tohoku J. Exp. Med. pmid:26156285
Ardeshirpour L et al. OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism. 2015 Endocrinology pmid:25961842
Reveille JD Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. 2015 Clin. Rheumatol. pmid:25939520
Bortolin RH et al. Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. 2015 PLoS ONE pmid:25933189
Wei J et al. Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. 2015 Mol Med Rep pmid:25891179
Su F et al. Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. 2015 Stem Cell Res Ther pmid:25888745
Dale MD et al. Bone-remodeling transcript levels are independent of perching in end-of-lay white leghorn chickens. 2015 Int J Mol Sci pmid:25625518
Ottewell PD et al. OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. 2015 Int. J. Cancer pmid:25603921
Son GY et al. Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. 2015 J. Dent. Res. pmid:25595364
Oostra DR et al. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. 2015 Mol. Cell. Endocrinol. pmid:25575458
Recker EN et al. A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. 2015 J. Periodontol. pmid:25269523
Hung JY et al. Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis. 2015 Int. J. Oncol. pmid:25738754

Table of Content